NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 28, 2026 — My ESA Therapist warns consumers to verify provider credentials and avoid fake ESA letters. Learn how to spot warning signs and make informed choices about online ESA evaluations.
October 27, 2026 — NanoViricides' Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo in the DRC is progressing, with Phase IIB expected after initial enrollment.
October 27, 2026 — A mutated flu version is spreading early on the West Coast, prompting urgent vaccination calls. Learn how decentralized testing tools from Co-Diagnostics and BioMedWire's news coverage keep you informed.
October 27, 2026 — Helus Pharma co-founders Eric So and Paul Glavine step down from executive roles, remain on board. Mark Lawson appointed independent chair. Clinical programs HLP003 and HLP004 advance.
October 27, 2026 — Tonix Pharmaceuticals presents Phase 3 data showing TONMYA improves fibromyalgia symptoms and function. New non-opioid treatment option shows promise.
October 27, 2026 — GeoVax Labs secures a $1M revolving loan from Bowery Consulting and appoints three new directors, boosting working capital for its GEO-MVA mpox vaccine program.
October 27, 2026 — Creative Biolabs launches tumor organoid and immune cell co-culture services, including CAR-T models, to advance preclinical immuno-oncology research with 3D tumor environments.
October 27, 2026 — Creative Biolabs launches an integrated OMV & exosome-boosted CAR-T development platform to help researchers overcome solid tumor barriers, from infiltration to persistence.
October 27, 2026 — Bertolino LLP awards 2026 Impact in Government Scholarship to Ajok "Jolie" Bul for her video on sunscreen regulation and the future of cosmetics law.
October 26, 2026 — GeoVax Labs secures a $1M revolving loan from Bowery Consulting Group, appoints three new directors, and advances its GEO-MVA vaccine program toward a Phase 3 trial.
October 26, 2026 — Carl Zeiss Meditec appoints Bronwyn Brophy O’Connor as CEO, effective Dec 1, 2026. She succeeds interim CEO Andreas Pecher and joins the ZEISS Executive Board.
October 26, 2026 — Viromed Medical AG completes capital increase, raising EUR 2 million through 450,000 new shares at EUR 4.50 each to fund working capital and support cold plasma technology growth.
October 26, 2026 — SS Innovations (NASDAQ: SSII) announces successful telesurgeries using SSi Mantra and SSi MantrAsana at EACTS and SRS India conferences, advancing remote robotic surgery.
October 26, 2026 — HeartBeam (NASDAQ: BEAT) gains FDA TAP Pilot acceptance for its 3D ECG heart attack assessment tech, advancing toward pivotal study and potential market entry.
October 26, 2026 — SS Innovations' SSi Mantra surgical robot completes remote telesurgeries at EACTS and SRS India, showcasing advanced tele-surgery capabilities and global potential.
October 26, 2026 — TransCode Therapeutics reports positive Phase 1a data for TTX-MC138 in advanced solid tumors, showing no dose-limiting toxicities and disease stabilization. Full results at ESMO 2026.
October 26, 2026 — Oncotelic Therapeutics announces peer-reviewed study in Biomedicines showing its AI-powered PDAOAI platform identified a four-gene prognostic signature for hepatocellular carcinoma, validated in 203 patients.
October 26, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) will report Q3 2026 financial results and operational highlights on Nov. 9, 2026. The call will cover progress on TONMYA and its CNS and immunology pipelines.
October 26, 2026 — Leading health groups release first shared guidance on women's heart health, introducing a Female Life Stage framework to prevent cardiovascular disease from puberty through menopause.
October 26, 2026 — New papers in Circulation urge a life-stage approach to women's heart health, linking hormones, mental health, and heart health from puberty to menopause.